DOJ: Google must sell Chrome to end monopoly

Date:

Share post:


The United States Department of Justice argued Wednesday that Google should divest its Chrome browser as part of a remedy to break up the company’s illegal monopoly in online search, according to a U.S District Court of the District of Columbia filing. Google would not be allowed to re-enter the search market for five years if the DOJ’s proposed remedy is approved.

Ultimately, it will be up to U.S. District of Columbia District Court Judge Amit Mehta to decide what Google’s final punishment will be, a decision that could fundamentally change one of the world’s largest businesses and alter the structure of the internet as we know it. That phase of the trial is expected to kick off sometime in 2025.

Judge Mehta ruled in August that Google was an illegal monopoly for abusing its power over the search business. The judge also took issue with Google’s control of various gateways to the internet, and the company’s payments to third parties in order to retain its status as a default search engine. 

The Justice Department proposed other remedies to address the search giant’s monopoly, including that Google spin off its Android mobile operating system. Prosecutors also argued the company should be prohibited from entering into exclusionary third-party contracts with browser or phone companies, such as Google’s contract to be the default search engine on all Apple products.

The Wednesday filing confirms earlier reports that prosecutors were considering pushing Google to spin off Chrome, which controls about 61% of the browser market in the U.S., according to web traffic service StatCounter.

Google did not immediately respond to TechCrunch’s request for comment.

This story is developing…



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Sam Altman disputes Marc Andreessen’s description of AI meetings with Biden administration

Famed investor Marc Andreessen recently talked about meetings with Biden administration staff who gave him the impression...

EV startup Canoo places remaining employees on a ‘mandatory unpaid break’

Struggling electric van startup Canoo has placed its remaining employees on what it’s calling a “mandatory unpaid...

After causing outrage on the first day of Y Combinator, AI code editor PearAI lands $1M seed

On the first day of Y Combinator’s winter 2024 session – right after orientation and a photo...

Third member of LockBit ransomware gang has been arrested

U.S. prosecutors in New Jersey on Friday publicly announced charges against Rostislav Panev, 51, a dual Russian-Israeli...

Feds clear the way for robotaxis without steering wheels and pedals

The National Highway Traffic Safety Administration (NHTSA) on Friday proposed a new national framework that could make...

VCs pledge not to take money from Russia or China, and Databricks raises a humongous round

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of...

Nvidia clears regulatory hurdle to acquire Run:ai

Chip company Nvidia gets the green light from the European Union to complete its acquisition of Run:ai. The...

Google is expanding Gemini’s in-depth research mode to 40 languages

Google said Friday that the company is expanding Gemini’s latest in-depth research mode to 40 more languages. The...